Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse

Drug Metabolism and Disposition

Volumn 40, Issue 4, 2012, Pages 671-679

  Kobayashi, Yuki ^a   Fukami, Tatsuki ^a   Nakajima, Akinori ^a   Watanabe, Akinobu ^a   Nakajima, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLACETAMIDE DEACETYLASE; ESTERASE; FLUTAMIDE; MESSENGER RNA; PHENACETIN; RECOMBINANT ENZYME; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLADDER; CATALYSIS; CONTROLLED STUDY; DRUG HYDROLYSIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; JEJUNUM; KIDNEY; LIVER; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; CARBOXYLIC ESTER HYDROLASES; CELL LINE; DRUG DISCOVERY; FEMALE; FLUTAMIDE; GASTROINTESTINAL TRACT; HYDROLYSIS; KIDNEY; LIVER; MALE; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PHENACETIN; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RIFAMPIN; RNA, MESSENGER; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION;

RATTUS;

EID: 84858425241     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.043067     Document Type: Article

References (29)

1. Bartsch H, Malaveille C, Camus AM, Martel-Planche G, Brun G, Hautefeuille A, Sabadie N, Barbin A, Kuroki T, Drevon C, et al. (1980) Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat Res 76:1-50. (Pubitemid 10066844)
2. Binda G, Domenichini E, Gottardi A, Orlandi B, Ortelli E, Pacini B, and Fowst G (1971) Rifampicin, a general review. Arzneimittelforschung 21:1907-1977.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Butler MA, Iwasaki M, Guengerich FP, and Kadlubar FF (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86:7696-7700. (Pubitemid 19265255)
5. Chan K (1987) [A simultaneous determination of rifampin and 25-deacetylrifampicin in cerebrospinal fluid and plasma of rabbit by liquid chromatography]. Zhongguo Yao Li Xue Bao 8:555-559.
6. Emoto C, Yamazaki H, Yamasaki S, Shimada N, Nakajima M, and Yokoi T (2000) Characterization of cytochrome P450 enzymes involved in drug oxidations in mouse intestinal microsomes. Xenobiotica 30:943-953.
7. Fukami T, Nakajima M, Maruichi T, Takahashi S, Takamiya M, Aoki Y, McLeod HL, and Yokoi T (2008) Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. Pharmacogenet Genomics 18:911-920.
8. Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, and Yu MC (1999) Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer 81:542-548.
9. Gangadharam PR (1986) Isoniazid, rifampin, and hepatotoxicity. Am Rev Respir Dis 133:963-965.
10. Goda R, Nagai D, Akiyama Y, Nishikawa K, Ikemoto I, Aizawa Y, Nagata K, and Yamazoe Y (2006) Detection of new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl) phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. Drug Metab Dispos 34:828-835.
11. Grange JM, Winstanley PA, and Davies PD (1994) Clinically significant drug interactions with antituberculosis agents. Drug Saf 11:242-251. (Pubitemid 24308247)
12. Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, Ishibashi S, Lehner R, Miyazaki M, Perkins EJ, et al. (2010) Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Mamm Genome 21:427-441.
13. Jensen CB and Jollow DJ (1991) The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol 111:1-12.
14. Katchen B and Buxbaum S (1975) Disposition of a new, nonsteroid, antiandrogen, α,α,α-trifluoro-2-methyl-4′-nitro-m- propionotoluidide (Flutamide), in men following a single oral 200 mg dose. J Clin Endocrinol Metab 41:373-379.
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Luan L, Sugiyama T, Takai S, Usami Y, Adachi T, Katagiri Y, and Hirano K (1997) Purification and characterization of pranlukast hydrolase from rat liver microsomes: the hydrolase is identical to carboxylesterase pI 6.2. Biol Pharm Bull 20:71-75. (Pubitemid 27065808)
17. Matsushima T, Yahagi T, Takamoto Y, Nagao M, and Sugimura T (1980) Species differences in microsomal activation of mutagens and carcinogens, with special reference to new potent mutagens from pyrolysates of amino acids and proteins, in Microsomes, Drug Oxidations, and Chemical Carcinogenesis, pp 1093-1102, Academic Press, New York.
18. Nakajima A, Fukami T, Kobayashi Y, Watanabe A, Nakajima M, and Yokoi T (2011) Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine. Biochem Pharmacol 82:1747-1756.
19. Nohmi T, Yoshikawa K, Nakadate M, and Ishidate M Jr (1983) Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes. Biochem Biophys Res Commun 110:746-752. (Pubitemid 13146712)
20. Probst MR, Beer M, Beer D, Jenö P, Meyer UA, and Gasser R (1994) Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase. J Biol Chem 269:21650-21656.
21. Sanghani SP, Davis WI, Dumaual NG, Mahrenholz A, and Bosron WF (2002) Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. Eur J Biochem 269:4387-4398.
22. Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, and La Du BN (2002) Current progress on esterases: from molecular structure to function. Drug Metab Dispos 30:488-493.
23. Schulz M, Schmoldt A, Donn F, and Becker H (1988) The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur J Clin Pharmacol 34:633-636.
24. Sicardi SM, Martiarena JL, and Iglesias MT (1991) Mutagenic and analgesic activities of aniline derivatives. J Pharm Sci 80:761-764.
25. Tenconi LT and Beretta E (1970) Urinary and biliary metabolites of rifampicin in different animal species. Proc Eur Soc Drug Toxit 11:80-85.
26. Trickett JI, Patel DD, Knight BL, Saggerson ED, Gibbons GF, and Pease RJ (2001) Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation. J Biol Chem 276:39522-39532.
27. Watanabe A, Fukami T, Nakajima M, Takamiya M, Aoki Y, and Yokoi T (2009) Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis. Drug Metab Dispos 37:1513-1520.
28. Watanabe A, Fukami T, Takahashi S, Kobayashi Y, Nakagawa N, Nakajima M, and Yokoi T (2010) Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen. Drug Metab Dispos 38:1532-1537.
29. Wirth PJ, Alewood P, Calder I, and Thorgeirsson SS (1982) Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR. Carcinogenesis 3:167-170. (Pubitemid 12120577)